Lv712
3260 积分 2024-03-07 加入
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
2天前
已完结
Apical bulkheads accumulate as adaptive responseto impaired bile flow in liver disease
1个月前
已完结
皖公网安备34019202002308
